Functional consequences of mutations in amino acid residues that stabilize calcium binding to the first epidermal growth factor homology domain of human protein C

Thrombosis and Haemostasis

Volumn 76, Issue 5, 1996, Pages 720-728

  Geng, Jie Ping ^a   Cheng, Chong Hui ^a   Castellino, Francis J ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 CARBOXYGLUTAMIC ACID; ACTIVATED PROTEIN C; ALANINE; AMINO ACID; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8A; CALCIUM BINDING PROTEIN; EPIDERMAL GROWTH FACTOR; GLUTAMIC ACID DERIVATIVE; MONOCLONAL ANTIBODY; MUTANT PROTEIN; PROTEIN C; THROMBIN; THROMBOMODULIN;

AMINO TERMINAL SEQUENCE; ANTICOAGULATION; ARTICLE; BINDING SITE; CALCIUM BINDING; CARBOXYLATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYDROXYLATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PROCESSING;

EID: 0029908173     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650650     Document Type: Article

References (46)

1. Kisiel W, Canfield WM, Ericsson LH, Davie EW. Anticoagulant properties of bovine plasma protein C following activation by thrombin. Biochemistry 1977; 16: 5824-31.
2. Vehar GA, Davie EW. Preparation and properties of bovine factor VIII (antihemophilic factor). Biochemistry 1980; 19: 401-10.
3. Esmon NL, Owen WG, Esmon CT. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 1982; 257: 859-64.
4. Amphlett GW, Kisiel W, Castellino FJ. Interaction of calcium with bovine plasma protein C. Biochemistry 1981; 20: 2156-61.
5. Clarke JH, Light DR, Blasko E, Parkinson JF, Nagashima M, McLean K, Vilander L, Andrews JH, Morser J, Glaser CB. The short loop between epidermal growth factor-like domains 4 and 5 is critical for human thrombomodulin function. J Biol Chem 1993; 268: 6309-15.
6. Colpitts TL, Castellino FJ. Calcium and phospholipid binding properties of synthetic gamma-carboxyglutamic acid-containing peptides with sequence counterparts in human protein C. Biochemistry 1994; 33: 3501-8.
7. Nelsestuen GL. Role of γ-carboxyglutamic acid. An unusual protein transition required for the calcium-dependent binding of prothrombin to phospholipid. J Biol Chem 1976; 251: 5648-56.
8. Öhlin A-K, Linse S, Stenflo J. Calcium binding to the epidermal growth factor homology region of bovine protein C. J Biol Chem 1988; 263: 7411-7.
9. Rezaie AR, Esmon NL, Esmon CT The high affinity calcium-binding site involved in protein C activation is outside of the first epidermal growth factor homology domain. J Biol Chem 1992; 267: 11701-4.
10. Rezaie AR, Esmon CT. The function of calcium in protein C activation by thrombin and the thrombin-thrombomodulin complex can be distinguished by mutational analysis of protein C derivatives. J Biol Chem 1992; 267: 26104-9.
11. Zhang L, Castellino FJ. Role of the hexapeptide disulfide loop present in the 7-carboxyglutamic acid domain of protein C in its activation properties and in the in vitro anticoagulant activity of activated protein C. Biochemistry 1991; 30: 6696-704.
12. 2+ for rapid activation by the thrombin-thrombomodulin complex. J Biol Chem 1994; 269: 3151-4.
13. Rees DJG, Nones IM, Handford PA, Walter SJ, Esnouf MO, Smith KJ, Brownlee GG. The role of β-hydroxyaspartic acid and adjacent carboxylate residues in the first EGF domain of human factor IX. EMBO J 1988; 7: 2053-61.
14. 2+ binding to EGF-like domains. Protein Eng 1992; 5: 489-94.
15. 2-terminal EGF-like domain in coagulation factor X. J Biol Chem 1992; 267: 19642-9.
16. Handford PA, Mayhew M, Baron M, Winship PR, Campbell ID, Brownlee GG. Key residues involved in calcium-binding motifs in EGF-like proteins. Nature 1991; 351: 164-7.
17. 2+-binding epidermal growth factor-like domain: Its role in protein-protein interactions. Cell 1995; 82: 131-421.
18. 7D) of human activated protein C displays greatly reduced activity as an anti-coagulant. Biochemistry 1990; 29: 10828-34.
19. Meyback B, Heim J, Rink H, Zimmermann W, Maerki W. Desulfatohirudin, a specific thrombin inhibitor: Expression and secretion in yeast. Thromb Res 1987; 7 (Suppl.): 33.
20. Heeb MJ, Schwartz P, White T, Lämmle B, Berrettini M, Griffin J. Immunoblotting studies of the molecular forms of protein C in plasma. Thromb Res 1988; 52: 33-43.
21. Wakabayashi K, Sakata Y, Aoki N. Conformation-specific monoclonal antibodies to the calcium-induced structure of protein C. J Biol Chem 1986; 261: 11097-105.
22. Suzuki K, Kusumoto H, Deyashiki Y, Nishioka J, Maruyami I, Zushi M, Kawahara S, Honda G, Yamamoto S, Horiguchi S. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J 1987; 6: 1891-7.
23. Glaser CB, Morser J, Clarke JH, Blasko E, McLean K, Kuhn I, Chang RJ, Lin JH, Vilander L, Andrews WH, Light DR. Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation. J Clin Invest 1992; 90: 2565-73.
24. Kunkel TA, Roberts JD, Zakour RA, Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods in Enzymol 1987; 154: 367-82.
25. Yu S, Zhang L, Jhingan A, Christiansen WT, Castellino FJ. Construction, expression, and properties of a recombinant human protein C with replacement of its growth factor-like domains by those of human coagulation factor IX. Biochemistry 1994; 33: 823-31.
26. Zhang L, Jhingan A, Castellino FJ. Role of individual gamma-carboxyglutamic acid residues of activated human protein C in defining its in vitro anti-coagulant activity. Blood 1992; 80: 942-52.
27. Jhingan A, Zhang L, Christiansen WT, Castellino FJ. The activities of recombinant gamma-carboxyglutamic acid-deficient mutants of activated human protein C toward human coagulation factor VIII and factor Va in purified systems and in plasma. Biochemistry 1994; 33: 1869-75.
28. Menhart N, Sehl LC, Kelley RF, Castellino FJ. Construction, expression and purification of recombinant kringle 1 of human plasminogen and analysis of its interaction with w-amino acids. Biochemistry 1991; 30: 1948-57.
29. De Serrano VS, Menhart N, Castellino FJ. The expression, purification and characterization of the recombinant kringle 1 domain from tissue-type plasminogen activator. Arch Biochem Biophys 1992; 294: 282-90.
30. De Serrano VS, Castellino FJ. The role of tryptophan-74 of the recombinant kringle 2 domain of tissue-type plasminogen activator in its ω-amino acid binding properties. Biochemistry 1992; 31: 3326-35.
31. Grinnell BW, Walls JD, Gerlitz B. Glycosylation of human protein C affects its secretion, processing, functional activities, and activation by thrombin. J Biol Chem 1991; 266: 9778-85.
32. Handford PA, Baron M, Mayhew M, Willis A, Beesley T, Brownlee GG, Campbell ID. The first EGF-like domain of human factor IX contains a high-affinity calcium binding site. EMBO J 1990; 9: 475-80.
33. Rezaie AR, Neuenschwander PF, Morrissey JH, Esmon CT Analysis of the functions of the first epidermal growth factor-like domain of factor X. J Biol Chem 1993; 268: 8176-80.
34. Selander-Sunnerhagen MS, Persson E, Dahlqvist I, Drakenberg T, Stenflo J, Mayhew M, Robin M, Handford P, Tilley JW, Campbell ID, Brownlee GG. The effect of aspartate hydroxylation on calcium binding to epidermal growth factor-like modules in coagulation factors IX and X. J Biol Chem 1993; 268: 23339-44.
35. 2-terminal epidermal growth factor-like module of factor X. Effect of the gamma-carboxyglutamic acid-containing module. J Biol Chem 1993; 268: 26673-8.
36. 2+ binding and biological activity. J Biol Chem 1988; 263: 19240-8.
37. Alabama-A point mutation in a clotting protein results in hemophilia B. Blood 1987; 69: 140-3.
38. McCord DM, Monroe DM, Smith KJ, Roberts HR. Characterization of the functional defect in factor IX Alabama. Evidence for a conformational change due to high affinity calcium binding in the first epidermal growth factor domain. J Biol Chem 1990; 265: 10250-4.
39. 2+ binding domains of factor IX: Importance of a β-OH64 → Asn change. Br J Haematol 1991; 77: 102-9.
40. Green PM, Bentley DR, Mibashan RS, Nilsson IM, Gianelli F. Molecular pathology of haemophilia B. EMBO J 1989; 8: 1067-72.
41. Bode W, Huber R, Rydel TJ, Tulinsky A, in Thrombin pp. 3-61.
42. Colpitts TL, Castellino FJ. Binding of calcium to synthetic peptides containing gamma-carboxyglutamic acid. Int J Peptide Protein Res 1993; 41: 567-75.
43. Bode W, Schwager P. Single calcium-binding site of crystalline bovine β-trypsin. FEBS Lett 1975; 56: 139-43.
44. 2+-binding site in the serine protease domain of human factor Vila and its role in tissue factor binding and development of catalytic activity. J Biol Chem 1995; 270: 15523-30.
45. 2+-binding site in the protease domain. Proc Natl Acad Sci USA 1992; 89: 152-6.
46. Esmon NL, DeBault LE, Esmon CT. Proteolytic formation and properties of v-carboxyglutamic acid-domainless protein C. J Biol Chem 1983; 258: 5548-53.